Biphasic control of the B cell transcriptome by mTORC1 and GSK3

mTORC1 和 GSK3 对 B 细胞转录组的双相调控

阅读:9
作者:Jens Kalchschmidt ,Tomoya Kanno ,Solji Park ,Wendy D Dubois ,Yongbing Zhao ,Pawel Trzaskoma ,Craig J Thomas ,Louis M Staudt ,John J O'Shea ,Seolkyoung Jung ,Rafael Casellas

Abstract

A central question in immune regulation is how cells coordinate transcriptional responses to environmental cues. It remains unclear whether transcriptional regulation is controlled by isolated mechanism or integrated regulatory programs. Here, we develop a high-sensitivity, genome-wide CRISPR-Cas9 screening platform with 47 transcriptional reporters in human B cell lymphoma, identifying 4,440 regulators and 17,638 regulatory interactions. To enable the exploration of these networks, we establish B-LEARN, an interactive portal for data visualization and discovery. Our results reveal a large number of shared regulators across our 47 screens that act as context-dependent activators or repressors. Globally, we uncover a biphasic regulatory architecture in which mTORC1 and GSK3 exert opposing control over the B cell transcriptome. Notably, mTOR inhibition broadly activates key B cell genes, an effect antagonized by GSK3. Thus, B cell transcription is governed by an integrated, pathway-driven circuit, offering new targets to modulate gene expression in lymphoma and autoimmune disease. Keywords: CP: Immunology; GSK3; functional CRISPR screens; gene regulatory network; human B cell lymphoma; immune response gene expression; mTOR; reporter cell lines; small-molecule screening; transcriptional regulation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。